Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-25T05:14:53.744Z Has data issue: false hasContentIssue false
  • English
  • Français

Addressing issues in health technology assessment promotion: Motives, enablers, and barriers

Published online by Cambridge University Press:  25 January 2011

Abinaya Rajan ,
Iñaki Gutierrez-Ibarluzea  and
Montse Moharra
Abinaya Rajan
Affiliation:
European Masters in Sustainable Regional Health Systems University of Deusto
Iñaki Gutierrez-Ibarluzea
Affiliation:
Osteba Basque Office for Health Technology Assessment and Nursing University School Vitoria-Gasteiz
Montse Moharra
Affiliation:
Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: The aim of this study was to analyze the motives, enablers, and barriers to promote or initiate health technology assessment (HTA) in different contexts.

Methods: An observational study design was used to address the above question that included a survey questionnaire and a two-phase study. The respondents for the questionnaire and first round of the study were from HTA agencies of high income countries and those low and middle income countries that have managed to establish HTA agencies (n = 50), that are members of International Network of Agencies for Health Technology Assessment (INAHTA), EuroScan, or European network for Health Technology Assessment (EUnetHTA). The second round of the study was exclusively with respondents from low and middle income countries that were manly affiliated to Health Technology Assessment International (HTAi) interest subgroup for low and middle income countries and aimed to initiate HTA activities (n = 34).

Results: Forty-one of fifty HTA agencies answered the survey questionnaire. Thirty-three of fifty individuals belonging to HTA agencies from high income countries and sixteen of thirty-four individuals from low and middle income countries answered in the first and second phases of the study, respectively. In the promotion and/or initiation of HTA, the top three motives were the same for both high income and low and middle income countries. The top three enablers were also similar but the prioritization varies. The top three barriers were more context specific.

Conclusions: HTA promotion or initiation is influenced by the following: (i) key players that affect the time taken to establish HTA agencies; (ii) three models for HTA promotion and initiation: top-down (political interest), bottom-up (academic/research interest), and converging (political and academic/research interests); and (iii) motives, enablers, and barriers at the local context.

Keywords

Technology assessmentObservational studyMotivesEnablersBarriers
Type
ASSESSMENTS
Information
International Journal of Technology Assessment in Health Care , Volume 27 , Issue 1 , January 2011 , pp. 55 - 63
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Altman, S, Blendon, R. Medical technology: The culprit behind health care costs? (DHEW Publication No. PHS 79-3216). Washington DC: U.S. Department of Health, Education and Welfare; 1977.Google Scholar
2. Banta, D. The development of health technology assessment. Health Policy. 2003;:121–123.CrossRefGoogle Scholar
3. Banta, D, Bryan, L. Health care technology and its assessment, an international perspective. New York: Oxford University Press; 1993:223–236.CrossRefGoogle Scholar
4. Banta, D, Gelband, H, Battista, RN, Jonsson, E. Health care technologies and its assessment in eight countries. Health Policy. 1994;30:1–3.CrossRefGoogle Scholar
5. Battista, R. Towards a paradigm for technology assessment. In: Peckham, M, Smith, R, eds. The scientific basis of health services. London: BMJ Publishing Group; 1996:11–18.Google Scholar
6. Coe, GA, Banta, D. Health care technology transfer in Latin America and the Caribbean. Int J Technol Assess Health Care. 1992;8:255–267.CrossRefGoogle ScholarPubMed
7. EUnetHTA. Handbook on HTA capacity building work package 8. Barcelona: Catalan Agency for Health Technology Assessment and Research; 2008.Google Scholar
8. Ham, C, Hunter, D, Robinson, R. Evidence based policy making. BMJ. 1995;71–72.CrossRefGoogle Scholar
9. Hutubessy, RC, Hanvoravongchai, P, Edejer, TT. Diffusion and utilization of magnetic resonance imaging in Asia. Int J Technol Assess Health Care. 2002;18:690–704.Google ScholarPubMed
10. Kristensen, FB. What is health technology assessment-and how is European Network for HTA (EUnetHTA) developing transnational collaboration? (2007, September) From International Society for Pharmacoeconomics and Outcomes Research: http://www.ispor.org/news/articles/Oct08/LatinAmericaHTA.asp (accessed August 15, 2010).Google Scholar
11. Moharra, M, Kubesch, N, Estrada, MD, et al. On behalf of work package 8, EUnetHTA project survey report on HTA orgamizations. Department of Health, Autonomous Government of Catalonia. Barcelona: Catalan Agency for Health Technology Assessment and Research; 2008.Google Scholar
12. OECD. www.oecd.org (accessed August 15, 2010).Google Scholar
13. Perleth, M, Jakubowski, E, Busse, R. What is “best practice” in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems. Health Policy. 2001;56:235–250.CrossRefGoogle Scholar
14. Sideman, S, BenDak, J. Assessing medical technology in less-developed countries. Int J Technol Assess Health Care. 1997;13:463–470.CrossRefGoogle ScholarPubMed
15. Sivalal, S. Health technology assessment in the Asia Pacific region. Int J Technol Assess Health Care. 2009;251:196–201.CrossRefGoogle Scholar
16. The World Bank. http://data.worldbank.org/country (accessed September 3, 2010).Google Scholar
17. Velasco-Garrido, M, Busse, R. Health technology assessment: An introduction to objectives, role of evidence, and structure in Europe. Geneva: World Health Organization, European Observatory on Health Systems and Policies; 2005.Google Scholar
18. Visalakshi, S, Mohan, S. Evaluation of biotechnology-based healthcare products for prioritization in Indian context. Int J Technol Assess Health Care. 2002;18:718–727.Google ScholarPubMed
19. WHO Regional Office for Europe. Institutionalization of health technology assessment. Bonn: World Health Organization; 2000.Google Scholar